Win for Added Relacorilant in Platinum-Resistant Ovarian Cancer

By News Health
2 days Ago

(MedPage Today) — CHICAGO — Combining investigational relacorilant with nab-paclitaxel (Abraxane) improved progression-free survival (PFS), and demonstrated a clinically meaningful trend towards an overall survival (OS) benefit, in patients…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115907

Author :

Publish date : 2025-06-04 19:07:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

The Head and the Heart: Managing a ‘Silent Epidemic’

Hyperinsulinemia Linked to Abnormal Uterine Bleeding

Should you be eating food products with fewer ingredients?

Winston Churchill's race to secure penicillin before D-Day found in notes

MD Denied COVID Vaccine; Pre-Med Jobs Ranked; Hand Surgeon Says No to Manicures

The Law Barring 'Surprise Billing' by Providers Has a Big Gap: Ground Ambulances